title: Liraglutide in clinical practice: Glycemic control, and predictors of good response.
authors.affiliation: Endocrinology and Nutrition Department, Arnau de Vilanova University Hospital, IRB-Lleida, UdL, Lleida, Spain. Electronic address: alecube@gmial.com.
authors.forename: Albert
authors.initials: A
authors.lastname: Lecube
authors.affiliation: Endocrinology and Nutrition Department, Gregorio Marañón University Hospital, Madrid, Spain.
authors.forename: Cyntia
authors.initials: C
authors.lastname: Gonzalez
authors.affiliation: Hospital de Día de Diabetes, Unidad de Investigación Clínica, Virgen Macarena University Hospital, UGC Provincial Endocrinologia y Nutrición, Sevilla, Spain.
authors.forename: Cristóbal
authors.initials: C
authors.lastname: Morales
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000069450:Liraglutide / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D000069450:Liraglutide; C517652:hemoglobin A1c protein, human